Role of hematopoietic microenvironment in plexiform neurofibroma progression
Role of hematopoietic microenvironment in plexiform neurofibroma progression
批准号:
8328651
负责人:
David W Clapp
金额:
$33.17万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
未结题
起止时间:
2005-09-20 至
关键词:
Adoptive TransferAdultAnimal ModelBiochemicalBiologicalBiological MarkersBloodBlood CirculationBlood VesselsBone Marrow CellsBone Marrow TransplantationCCL2 geneCSF1 geneCell AdhesionCell CommunicationCell ProliferationCell SurvivalCellsClinicClinical TrialsComplementComplexDiseaseDrug Delivery SystemsDysplasiaEndothelial CellsEndotheliumEngineeringEventExtracellular MatrixGelatinase BGeneticGrowth FactorHarvestHematopoieticHematopoietic SystemHumanHyperplasiaIn VitroInflammationInflammatoryIntegrin alpha4beta1IntegrinsLeadMMP9 geneMalignant - descriptorMalignant NeoplasmsMatrix MetalloproteinasesMediatingMedicalModelingMolecularMusMyelogenousMyeloid CellsNerveParacrine CommunicationPatientsPeptide HydrolasesPlexiform NeurofibromaPopulationPositron-Emission TomographyProcessProto-Oncogene Protein c-kitPublishingRoleSchwann CellsSignal TransductionSiteStem Cell FactorStromal CellsTestingTherapeuticTissuesTransplantationVascular Endothelial Growth FactorsWorkcohortcytokinein vivomacrophagemast cellmigrationneurofibromaperipheral bloodperipheral blood vesselpreventresearch studytumortumor progressiontumorigenic
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Plexiform neurofibromas are complex tumors characterized by tumorigenic Schwann cells, inflammatory cells, neoangiogenesis and alterations of the extracellular matrix. Our previous work provided genetic, cellular, and biochemical evidence that haploinsufficiency of Nfl alters Ras activity and cell fates in mast cells and that ckit activation of the hematopoietic system is required in the initiation of plexiform tumor formation in a murine model. In this application, we propose to build oh these observations to identify the underpinning mechanisms of how c-kit mediates its biological effects, and to identify experimental processes that would complement ckit mediated experimental therapeutics in the clinic. Three basic processes will be examined. First, kit activation is known to cooperate with integrin signals in enabling myeloid cells to adhere to blood vessel walls and emigrate from the blood to the emerging tumor. We have recently established that Nf 1 +/- mast cells
preferentially adhere to alpha4beta1, an integrin that has a key role in mast cell adhesion to endothelium and
in local sites of inflammation. We hypothesize that alpha4beta1 is crucial in the recruitment of Nf1+/- mast
cells to the tumor microenvironment in promoting local mast cell proliferation and survival, and in the
secretion of molecules that promote neoangiogenesis. We propose studies to test this hypothesis in vitro and in vivo. Second, MMPs are secreted molecules that promote the release of preformed growth factors to the circulation and degrade the extracellular matrix of tissues allowing invasion of inflammatory and stromal cells leading to tumor progression. In preliminary studies we detect one specific MMP that is preferentially expressed and activated. Studies to specifically test the role of this protease are proposed. Finally, the specific downstream paracrine signals that lead to alterations of the extracellular matrix and neoangiogenesis are incompletely understood. Tumor-associated macrophages are known to enhance neoangiogenesis and facilitate malignant outgrowth. We recently established that large populations of angiogenic macrophages are found in peripheral blood and in the neurofibromas of Krox20; Nfl flox/- mice. We hypothesize that macrophage recruitment and their role in neoangiogenesis is a key downstream event following mast cell recruitment to the tumor and, therefore, processes that inhibit this activity will prevent or delay tumor progression. Adoptive transfer experiments are proposed to test this hypothesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TAM receptor inhibition in NF1-associated peripheral nerve sheath tumors
-
批准号:10741104
-
项目类别:
-
资助金额:$4.42万
-
财政年份:2023
-
负责人:David W Clapp
-
依托单位:
Preclinical-clinical trials collaboration to effectively advance new combination therapies for atypical neurofibroma in neurofibromatosis type 1
-
批准号:10611130
-
项目类别:
-
资助金额:$49.56万
-
财政年份:2023
-
负责人:David W Clapp
-
依托单位:
Pediatric and Adult Translational Cancer Drug Discovery and Development Training Program (PACT-D3)
-
批准号:10708526
-
项目类别:
-
资助金额:$15.88万
-
财政年份:2023
-
负责人:David W Clapp
-
依托单位:
Indiana Pediatric Scientist Award (IPSA)
-
批准号:10598852
-
项目类别:
-
资助金额:$32.4万
-
财政年份:2023
-
负责人:David W Clapp
-
依托单位:
TAM receptor inhibition in NF1-associated peripheral nerve sheath tumors
-
批准号:10501263
-
项目类别:
-
资助金额:$41.52万
-
财政年份:2022
-
负责人:David W Clapp
-
依托单位:
TAM receptor inhibition in NF1-associated peripheral nerve sheath tumors
-
批准号:10913886
-
项目类别:
-
资助金额:$7.27万
-
财政年份:2022
-
负责人:David W Clapp
-
依托单位:
The Medical Physician Engineers, Scientists, and Clinicians Preparatory Program [MPESC-Prep]
-
批准号:10618993
-
项目类别:
-
资助金额:$16.03万
-
财政年份:2022
-
负责人:David W Clapp
-
依托单位:
TAM receptor inhibition in NF1-associated peripheral nerve sheath tumors
-
批准号:10616770
-
项目类别:
-
资助金额:$26.39万
-
财政年份:2022
-
负责人:David W Clapp
-
依托单位:
Mitotic failure in Fanconi anemia: mechanisms and role in carcinogenesis
-
批准号:10001741
-
项目类别:
-
资助金额:$4.66万
-
财政年份:2020
-
负责人:David W Clapp
-
依托单位:
F-box ubiquitin ligases destabilize neurofibromin
-
批准号:9767890
-
项目类别:
-
资助金额:$34.45万
-
财政年份:2018
-
负责人:David W Clapp
-
依托单位:
F-box ubiquitin ligases destabilize neurofibromin
-
批准号:10249088
-
项目类别:
-
资助金额:$34.45万
-
财政年份:2018
-
负责人:David W Clapp
-
依托单位:
F-box ubiquitin ligases destabilize neurofibromin
-
批准号:10011888
-
项目类别:
-
资助金额:$34.45万
-
财政年份:2018
-
负责人:David W Clapp
-
依托单位:
Developmental and Hyperactive Ras Tumor (DHART) SPORE
-
批准号:10494091
-
项目类别:
-
资助金额:$213.95万
-
财政年份:2015
-
负责人:David W Clapp
-
依托单位:
FRONTIERS IN SCIENCE CONFERENCE
-
批准号:10670908
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2015
-
负责人:David W Clapp
-
依托单位:
FRONTIERS IN SCIENCE CONFERENCE
-
批准号:9765354
-
项目类别:
-
资助金额:$0.6万
-
财政年份:2015
-
负责人:David W Clapp
-
依托单位:
PROJECT 1: From Neurofibroma to MPNST: Models, Biology and Translation to Clinic
-
批准号:10270581
-
项目类别:
-
资助金额:$57.08万
-
财政年份:2015
-
负责人:David W Clapp
-
依托单位:
FRONTIERS IN SCIENCE CONFERENCE
-
批准号:10460946
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2015
-
负责人:David W Clapp
-
依托单位:
Developmental and HyperActive Ras Tumor SPORE
-
批准号:9341155
-
项目类别:
-
资助金额:$227.18万
-
财政年份:2015
-
负责人:David W Clapp
-
依托单位:
Administrative Core
-
批准号:10270578
-
项目类别:
-
资助金额:$8.62万
-
财政年份:2015
-
负责人:David W Clapp
-
依托单位:
Project 1: Molecular and Genetic Features Across Mouse and Human Plexiform Neurofibromas to Inform Clinical Trials
-
批准号:8932162
-
项目类别:
-
资助金额:$12.38万
-
财政年份:2015
-
负责人:David W Clapp
-
依托单位:
海外基金